BioLumic

BioLumic is a New Zealand-based startup that focuses on developing light signals to unlock the natural genetic potential of seeds and seedlings. Founded in 2013, the company's technology works by programming plants with light, without the use of chemicals or genetic modification. This innovative approach triggers biological mechanisms, leading to increased plant yield, vigor, and disease resistance across a variety of crops including soybean, corn, cannabis, strawberries, leafy greens, and canola. The company recently secured a $13.50M Series B investment on 21st June 2022. The funding round involved participation from a notable group of investors including Canopy Rivers, Entourage Effect Capital, Icehouse Ventures, OurCrowd, Finistere Ventures, Braavos Investment Advisers, The Arcview Group, Rabo Ventures, Flatiron Venture Partners, and Virtu Financial. With a focus on the agriculture, biotechnology, and sustainability industries, BioLumic has demonstrated its potential to revolutionize the agricultural sector through its novel light signal treatments. This recent investment is poised to propel the company's growth and further establish its position as a pioneering force in enhancing crop productivity and resilience.